Effect of substance 101333-3 on emphysema and MMP activity in a model of cadmium-induced emphysema

L. Fiévez, N. Kirschvink, L. Provins, P. Gustin (Liège, Braine l‘Alleud, Belgium)

Source: Annual Congress 2005 - Exploring alternative mechanisms and treatments
Session: Exploring alternative mechanisms and treatments
Session type: Thematic Poster Session
Number: 3708
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Fiévez, N. Kirschvink, L. Provins, P. Gustin (Liège, Braine l‘Alleud, Belgium). Effect of substance 101333-3 on emphysema and MMP activity in a model of cadmium-induced emphysema. Eur Respir J 2005; 26: Suppl. 49, 3708

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Angiotensin-(1-7) therapy attenuates pulmonary emphysema and sickness behavior induced by elastase in a murine model
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019

Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice
Source: Eur Respir J 2006; 27: 1102-1109
Year: 2006



An inhaled MMP inhibitor blocks cigarette-induced lung damage in the smoking mouse model
Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work
Year: 2003


Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space
Source: Eur Respir J 2008; 32: 644-650
Year: 2008



Relationship between circulating serpina 3g, activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, 2 with chronic obstructive pulmonary disease severity
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018

Oral presentation: SOD3 protects cigarette smoke-induced emphysema associated with reduction of extracellular matrix fragmentation in mice
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

Effects of matrix metalloproteinase inhibitor on ventilator-induced lung injury in rats
Source: Eur Respir J 2002; 20: Suppl. 38, 486s
Year: 2002

The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Effect of curcumin on inflammation in experimental pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007


Aerobic exercise can impair lung fibrotic and functional response in a model of bleomycin-induced lung fibrosis: a time-dependent effect
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017

The attenuating effect of erythropoietin (EPO) on the expression of myeloperoxidase (MPO) in bleomycin-induced pulmonary fibrosis in rats
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013

PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced idiopathic pulmonary fibrosis by regulation of extracellular matrix remodelling
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013


Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients
Source: Eur Respir J 2005; 25: 885-890
Year: 2005



Collagen V activation and matrix extracellular remodeling mediated pulmonary fibrosis in experimental models of bleomycin and 3-5-di-tert-4-hidroxitoluene
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

The effect of tenascin-c deficiency on TGF-β-mediated fibrosis and alveolar inflammation in a murine model of ARDS
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009


Kinetics of extracellular matrix proteins and TGF-β in a rat lung model of elastase induced emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 197s
Year: 2001

Temporal analysis of macrophage infiltration, expression of metalloproteinase 12 and isoprostane-8 in an experimental model of emphysema
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010


Human macrophage elastase (MMP-12) expression in human emphysematous lungs: role in extracellular matrix remodelling in chronic obstructive pulmonary diseases (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001